LYNCEAN TECHNOLOGIES

lyncean-technologies-logo

Lyncean Technologies, Inc. is located in Fremont, California and was founded in 2001 to develop the Compact Light Source (CLS), a miniature synchrotron x-ray source, based on research performed at the SLAC National Accelerator Laboratory and Stanford University. Unlike stadium-sized synchrotron radiation sources that require a highly technical support staff, the CLS fits in a typical laboratory space and is designed to be operated directly by academic or industrial end-users. By replacing th... e conventional "undulator" magnets found in the large synchrotrons by laser technology, the entire device scales down in size by a factor of 200. Unlike traditional laboratory sources, the CLS makes a narrow beam of nearly monochromatic X-rays which are adjustable in energy. The first commercial Lyncean CLS was purchased in December 2012 by researchers from the newly formed Center for Advanced Laser Applications in Germany, a joint project of the Ludwig Maximilians University of Munich and the Technical University Munich (TUM). The Munich CLS was delivered at the end of 2014 and has been in routine operation since April 2015. Intellectual property developed at Lyncean Technologies, Inc. is protected by several patents.

#SimilarOrganizations #People #Financial #Website #More

LYNCEAN TECHNOLOGIES

Social Links:

Industry:
Advanced Materials Biotechnology Health Care Industrial Manufacturing Life Science Nanotechnology Semiconductor Therapeutics

Founded:
2002-01-01

Address:
Fremont, California, United States

Country:
United States

Website Url:
http://www.lynceantech.com

Total Employee:
11+

Status:
Active

Contact:
(650)320-8300

Email Addresses:
[email protected]

Total Funding:
19.76 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon WordPress Content Delivery Network Font Awesome Domain Not Resolving Sitelinks Search Box Euro


Similar Organizations

voyager-therapeutics-logo

Voyager Therapeutics

Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system


Current Advisors List

not_available_image

Ronald Ruth Chairman of the Board @ Lyncean Technologies
Board_member
2001-01-01

Current Employees Featured

not_available_image

Michael Feser
Michael Feser Chief Executive Officer @ Lyncean Technologies
Chief Executive Officer
2016-02-14

not_available_image

Rod Browning
Rod Browning Advisor to CEO / Board of DIrectors @ Lyncean Technologies
Advisor to CEO / Board of DIrectors
2016-03-01

not_available_image

Rod Loewen
Rod Loewen Chief Technology Officer @ Lyncean Technologies
Chief Technology Officer
2015-05-01

not_available_image

Jack Kasahara
Jack Kasahara VP of Business Development @ Lyncean Technologies
VP of Business Development
2016-08-08

sean-de-la-pena_image

Sean De La Pena
Sean De La Pena CEO @ Lyncean Technologies
CEO
2021-10-01

jay-chen_image

Jay Chen
Jay Chen VP Engineering @ Lyncean Technologies
VP Engineering

lon-ensler_image

Lon Ensler
Lon Ensler CFO @ Lyncean Technologies
CFO

chris-juan_image

Chris Juan
Chris Juan Director of Operations @ Lyncean Technologies
Director of Operations

not_available_image

Donald Schafer
Donald Schafer Senior Mechanical Engineer @ Lyncean Technologies
Senior Mechanical Engineer
2020-11-01

Founder


not_available_image

Jeff Rifkin

not_available_image

Rod Loewen

not_available_image

Ronald Ruth

Investors List

intel-capital_image

Intel Capital

Intel Capital investment in Series B - Lyncean Technologies

quintus-vermoegensverwaltung-gmbh_image

Quintus Vermoegensverwaltung GmbH

Quintus Vermoegensverwaltung GmbH investment in Series B - Lyncean Technologies

eurous-ventures_image

EuroUS Ventures

EuroUS Ventures investment in Series B - Lyncean Technologies

privilège-management_image

Privilège Management SA

Privilège Management SA investment in Series B - Lyncean Technologies

eurous-ventures_image

EuroUS Ventures

EuroUS Ventures investment in Series A - Lyncean Technologies

privilège-management_image

Privilège Management SA

Privilège Management SA investment in Series A - Lyncean Technologies

Official Site Inspections

http://www.lynceantech.com

  • Host name: 199.59.243.227
  • IP address: 199.59.243.227
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Lyncean Technologies" on Search Engine